Publications by authors named "Mario Larocca"

Claim this Profile
A
A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.
Luigi Tarantini, Giuseppina Gallucci, Alessandro Inno, Andrea Camerini, Maria Laura Canale, Mario Larocca

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The role of imaging in defining cardiovascular risk to help cancer patient management: a scoping review.
Roberto Farì, Giulia Besutti, Pierpaolo Pattacini, Guido Ligabue, Francesco Piroli, Mario Larocca

Insights Imaging· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of imaging in defining cardiovascular risk to help cancer patient management: a scoping review.
Roberto Farì, Giulia Besutti, Pierpaolo Pattacini, Guido Ligabue, Francesco Piroli, Mario Larocca

Insights Imaging· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management.
Giuseppina Gallucci, Mario Larocca, Alessandro Navazio, Fabio Maria Turazza, Alessandro Inno

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor].
Davide Bosi, Pierluigi Demola, Giulia Alberti, Sergio Musto D'Amore, Mario Larocca

G Ital Cardiol (Rome)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial.
Angela Damato, Francesca Bergamo, Lorenzo Antonuzzo, Guglielmo Nasti, Francesco Iachetta, Mario Larocca

Front Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Population-Based Study of Cardiovascular Disease Mortality in Italian Cancer Patients.
Lucia Mangone, Pamela Mancuso, Luigi Tarantini, Mario Larocca, Isabella Bisceglia

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Response and Prolonged Survival Following Pembrolizumab Discontinuation Due to Long-Lasting Autoimmune Colitis in Advanced NSCLC: A Case Report.
Angela Damato, Loredana De Marco, Silvia Serra, Mario Larocca, Alicia Garcia Arias

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Sabrina Rossi, Michele Basso, Antonia Strippoli, Giovanni Schinzari, Ettore D'Argento, Mario Larocca

Clin Colorectal Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Rhabdomyolysis during Treatment with Trabectedin in Combination with a Herbal Drug in a Patient with Metastatic Synovial Sarcoma: A Case Report.
Angela Damato, Mario Larocca, Ermanno Rondini, Massimo Menga, Carmine Pinto

Case Rep Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal stromal tumors (GISTs) and second malignancies: A novel "sentinel tumor"? A monoinstitutional, STROBE-compliant observational analysis.
Maria Grazia Rodriquenz, Sabrina Rossi, Riccardo Ricci, Maurizio Martini, Mario Larocca

Medicine (Baltimore)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis